• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量顺铂联合达卡巴嗪和他莫昔芬治疗转移性黑色素瘤。

High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.

作者信息

Buzaid A C, Murren J R, Durivage H J

机构信息

Department of Medicine, Yale New Haven Hospital, Yale University School of Medicine, Connecticut 06510.

出版信息

Cancer. 1991 Sep 15;68(6):1238-41. doi: 10.1002/1097-0142(19910915)68:6<1238::aid-cncr2820680609>3.0.co;2-#.

DOI:10.1002/1097-0142(19910915)68:6<1238::aid-cncr2820680609>3.0.co;2-#
PMID:1873775
Abstract

In an attempt to increase the antitumor effect of cisplatin (50 mg/m2) and dacarbazine (350 mg/m2), each repeated on days 1 to 3 every 4 weeks in patients with metastatic melanoma, tamoxifen was added to the regimen. Before the first course of chemotherapy, the patients received a loading dose of tamoxifen (100 mg orally twice a day for 7 days), followed by a maintenance dose of 10 mg orally twice a day and continued throughout the treatment. Aspirin (325 mg orally every other day) was administered at the same time as the tamoxifen in an attempt to reduce the risk of thromboembolic events. The activity of high-dose cisplatin with dacarbazine and tamoxifen was disappointing. Of 23 evaluable patients, only three responded--an overall response rate of 13% (95% confidence limits, 0% to 27%). These responses consisted of one pathologic complete remission in a patient with nodal metastases, one clinical complete remission in a patient with a very large pelvic mass, and one partial response in another patient with nodal metastases. The duration of responses was 12+, 4, and 4 months, respectively. These data do not support a significant interaction between tamoxifen and cisplatin or dacarbazine. Assuming that tamoxifen is important in the cisplatin, dacarbazine, and carmustine combination, as suggested by others, the most relevant interaction may be between tamoxifen and carmustine.

摘要

为提高顺铂(50mg/m²)和达卡巴嗪(350mg/m²)的抗肿瘤效果(二者在转移性黑色素瘤患者中每4周于第1至3天重复使用),在该方案中加入了他莫昔芬。在第一个化疗疗程前,患者接受他莫昔芬负荷剂量(口服100mg,每日2次,共7天),随后为维持剂量,口服10mg,每日2次,并在整个治疗过程中持续使用。阿司匹林(口服325mg,隔日1次)与他莫昔芬同时给药,以降低血栓栓塞事件的风险。高剂量顺铂联合达卡巴嗪及他莫昔芬的活性令人失望。在23例可评估患者中,仅3例有反应,总缓解率为13%(95%置信区间,0%至27%)。这些反应包括1例伴有淋巴结转移患者的病理完全缓解、1例盆腔巨大肿块患者的临床完全缓解以及另1例伴有淋巴结转移患者的部分缓解。缓解持续时间分别为12个月以上、4个月和4个月。这些数据不支持他莫昔芬与顺铂或达卡巴嗪之间存在显著相互作用。假设如其他人所建议的,他莫昔芬在顺铂、达卡巴嗪和卡莫司汀联合方案中很重要,那么最相关的相互作用可能存在于他莫昔芬与卡莫司汀之间。

相似文献

1
High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.大剂量顺铂联合达卡巴嗪和他莫昔芬治疗转移性黑色素瘤。
Cancer. 1991 Sep 15;68(6):1238-41. doi: 10.1002/1097-0142(19910915)68:6<1238::aid-cncr2820680609>3.0.co;2-#.
2
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.一项高剂量顺铂和达卡巴嗪的II期试验。高剂量基于顺铂的疗法对转移性黑色素瘤无效。
Cancer. 1991 Sep 15;68(6):1230-7. doi: 10.1002/1097-0142(19910915)68:6<1230::aid-cncr2820680608>3.0.co;2-q.
3
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.一项随机、双盲、安慰剂对照试验,比较卡莫司汀、达卡巴嗪和顺铂联合或不联合他莫昔芬治疗转移性黑色素瘤患者的缓解率。加拿大国家癌症研究所临床试验组。
J Clin Oncol. 1996 Jul;14(7):2083-90. doi: 10.1200/JCO.1996.14.7.2083.
4
Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma.达卡巴嗪、顺铂、福莫司汀和他莫昔芬联合治疗转移性恶性黑色素瘤。
Melanoma Res. 1998 Apr;8(2):170-4. doi: 10.1097/00008390-199804000-00012.
5
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study.卡莫司汀、达卡巴嗪、顺铂和他莫昔芬治疗晚期黑色素瘤的II期研究:一项西南肿瘤学组的研究
J Clin Oncol. 1998 Feb;16(2):664-9. doi: 10.1200/JCO.1998.16.2.664.
6
The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma.
Cancer. 1989 Apr 1;63(7):1292-5. doi: 10.1002/1097-0142(19890401)63:7<1292::aid-cncr2820630711>3.0.co;2-i.
7
Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.联合化疗与激素疗法治疗恶性黑色素瘤
Cancer Treat Rep. 1987 May;71(5):465-9.
8
Interferon-alpha and chemohormonal therapy for patients with advanced melanoma: final results of a phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program.
Cancer. 1998 May 1;82(9):1677-81. doi: 10.1002/(sici)1097-0142(19980501)82:9<1677::aid-cncr13>3.0.co;2-1.
9
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921).他莫昔芬联合达卡巴嗪和顺铂用于转移性恶性黑色素瘤的治疗。西南肿瘤协作组(SWOG-8921)的一项II期试验。
Am J Clin Oncol. 1996 Apr;19(2):108-13. doi: 10.1097/00000421-199604000-00004.
10
High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma.大剂量顺铂联合达卡巴嗪治疗转移性黑色素瘤。
Cancer. 1991 Mar 15;67(6):1514-7. doi: 10.1002/1097-0142(19910315)67:6<1514::aid-cncr2820670609>3.0.co;2-q.

引用本文的文献

1
Estradiol differently affects melanin synthesis of malignant and normal melanocytes: a relationship with clock and clock-controlled genes.雌二醇对恶性黑素细胞和正常黑素细胞的黑色素合成有不同影响:与生物钟及生物钟调控基因的关系。
Mol Cell Biochem. 2016 Oct;421(1-2):29-39. doi: 10.1007/s11010-016-2781-3. Epub 2016 Aug 18.
2
Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin.他莫昔芬、17β-雌二醇和钙调蛋白拮抗剂J8可抑制人黑色素瘤细胞通过纤连蛋白的侵袭。
Br J Cancer. 1997;75(6):860-8. doi: 10.1038/bjc.1997.153.